Angioedema due to angiotensin-converting enzyme inhibitors.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Immunopharmacology

• Publication date

  1999-10-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0162-3109(99)00107-1PMID 10604520
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Recurrent Angiotensin‐Converting Enzyme Inhibitor‐Associated Angioedema

  1998cited by this paper
• ACE Inhibitor-Induced Angioedema

  1998cited by this paper
• Plasma bradykinin in angio-oedema.

  1998cited by this paper
• Rapid Direct Determination of Low and High Molecular Weight Kininogen in Human Plasma by Particle Concentration Fluorescence Immunoassay (PCFIA)

  1997cited by this paper
• Angioedema: the role of ACE inhibitors and factors associated with poor clinical outcome

  1997cited by this paper
• Angiotensin–converting enzyme (ACE) inhibitors and angio–oedema

  1997cited by this paper
• Examination of baseline levels of carboxypeptidase N and complement components as potential predictors of angioedema associated with the use of an angiotensin-converting enzyme inhibitor.

  1997cited by this paper
• An adverse reaction to angiotensin-converting enzyme inhibitors in a patient with neglected C1 esterase inhibitor deficiency.

  1997cited by this paper
• Recurrent angiotensin-converting enzyme inhibitor-associated angioedema

  1997cited by this paper
• Images in clinical medicine. Angioedema of the intestine.

  1996cited by this paper
• Angioedema of the Intestine

  1996cited by this paper
• Activation of factor XII and cleavage of high molecular weight kininogen during acute attacks in hereditary and acquired C1-inhibitor deficiencies.

  1996cited by this paper
• Black Americans have an increased rate of angiotensin converting enzyme inhibitor‐associated angioedema

  1996cited by this paper
• Plasma kinins increase after angiotensin-converting enzyme inhibition in human subjects.

  1994cited by this paper
• Contraindications to the use of ace inhibitors in patients with C1 esterase inhibitor deficiency.

  1991cited by this paper
• Studies of the mechanism of angiotensin-converting enzyme (ACE) inhibitor-associated angioedema: the effect of an ACE inhibitor on cutaneous responses to bradykinin, codeine, and histamine.

  1990cited by this paper
• Clinical profile of angioedema associated with angiotensin converting-enzyme inhibition.

  1988cited by this paper
• Detection of in vitro and in vivo cleavage of high molecular weight kininogen in human plasma by immunoblotting with monoclonal antibodies.

  1986cited by this paper
• A Simple Spectrophotometric Assay of Carboxypeptidase N (Kininase I) in Human Serum

  1983cited by this paper
• Prekallikrein activation and high-molecular-weight kininogen consumption in hereditary angioedema.

  1983cited by this paper
• An enzyme in human blood plasma that inactivates bradykinin and kallidins.

  1962cited by this paper

• Measurement of cleaved high-molecular-weight kininogen in patients with hereditary angioedema due to C1-inhibitor deficiency: preanalytical and analytical optimization.

  2025cites this paper
• Bradykinin-Mediated Angioedema Induced by Drugs

  2025cites this paper
• High‐Throughput Screening for Prescribing Cascades Among Real‐World Angiotensin‐II Receptor Blockers (ARBs) Initiators

  2025cites this paper
• High-Throughput Screening for Prescribing Cascades Among Real-World Angiotensin-II Receptor Blockers (ARBs) Initiators

  2025cites this paper
• High‐Throughput Screening for Prescribing Cascades Among Real‐World Angiotensin‐Converting Enzyme Inhibitor Initiators

  2025cites this paper
• Contact system activation and bradykinin generation in patients with idiopathic angioedema.

  2024cites this paper
• Contact System Activation and Bradykinin Generation in Angioedema: Laboratory Assessment and Biomarker Utilization.

  2024cites this paper
• Bradykinin-Mediated Angioedema Induced by Commonly Used Cardiovascular Drugs

  2023cites this paper
• Initial characteristics and follow-up of patients with a diagnosis of angiotensin-converting enzyme inhibitor induced angioedema.

  2022cites this paper
• Interventions for the long-term prevention of hereditary angioedema attacks.

  2022cites this paper
• Lisinopril-Induced Small Bowel Angioedema: An Unusual Cause of Severe Abdominal Pain

  2022cites this paper
• Angioedema without wheals: a clinical update

  2021cites this paper
• Increased Risk of Urticaria/Angioedema after BNT162b2 mRNA COVID-19 Vaccine in Health Care Workers Taking ACE Inhibitors

  2021cites this paper
• Letter to the Editor

  2021cites this paper
• Identification of novel biomarkers to distinguish bradykinin‐mediated angioedema from mast cell‐/histamine‐mediated angioedema

  2021cites this paper
• Perioperative Management of Patients With Hereditary Angioedema With Special Considerations for Cardiopulmonary Bypass

  2020cites this paper
• The rash that presents as a red swollen face.

  2020cites this paper
• Coronary Artery Disease: Therapeutics and Drug Discovery

  2020cites this paper
• Hypertension Drug Therapy.

  2020cites this paper
• Adverse reactions induced by ACEIs are secondary to interference with the renin‐angiotensin‐aldosterone system (RAAS), which is responsible for the development and progression of cardiovascular and renal disorders. ACEIs block angiotensin‐converting enzyme (ACE) activity, decrease conversion of angi

  2020cites this paper
• Hereditary angioedema: report of the dental treatment of 12 Brazilian patients.

  2020cites this paper
• Acquired angioedema induced by angiotensin-converting enzyme inhibitors - experience of a hospital-based allergy center.

  2020cites this paper
• Angiotensin II receptor blockers are safe in patients with prior angioedema related to angiotensin‐converting enzyme inhibitors – a nationwide registry‐based cohort study

  2019cites this paper
• DHPS_A_205119 105..113

  2019influential citation
• ACE-Inhibitor Related Angioedema Is Not Sufficiently Reported to the Danish Adverse Drug Reactions Database

  2019cites this paper
• ACE inhibitor-mediated angioedema.

  2019cites this paper
• Interventions for the treatment of acute hereditary angioedema attacks

  2019cites this paper
• Interventions for the long-term prevention of hereditary angioedema attacks

  2019cites this paper
• Os Vários Tipos de Angioedema: Classificação,

  2019cites this paper
• Genetic susceptibility to angiotensin-converting enzyme-inhibitor induced angioedema: A systematic review and evaluation of methodological approaches

  2019cites this paper
• Angiotensin-Converting Enzyme Inhibitors in Hypertension: To Use or Not to Use?

  2018cites this paper
• Exploring the C-domain inhibition of angiotensin converting enzyme through novel bradykinin potentiating peptides

  2018cites this paper
• A PROSPECTIVE STUDY TO ANALYSE THE SIDE EFFECTS OF OLMESARTAN MEDOXOMIL AND ENALAPRIL IN HYPERTENSIVE SUBJECTS

  2018cites this paper
• Clinical experiences and case review of angiotensin II receptor blocker‐related angioedema in Korea

  2018cites this paper
• Hereditary Angioedema in Sweden : a National Project

  2017cites this paper
• Potential Biomarkers for the Diagnosis of Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema

  2017cites this paper
• Bradykinin in idiopathic non‐histaminergic angioedema

  2017cites this paper
• Laboratory Approaches for Assessing Contact System Activation.

  2017cites this paper
• About a Case of Neurotic Angioedema Induced by Angiotensin Converting Enzyme Inhibitor

  2017cites this paper
• The Angiotensin-Converting-Enzyme-Induced Angioedema.

  2017cites this paper
• How we manage persons with hereditary angioedema

  2016cites this paper
• Angioedema Due to ACE Inhibitors

  2016cites this paper
• HAE Pathophysiology and Underlying Mechanisms

  2016influential citation
• Adverse drug reactions and organ damage: The skin.

  2016cites this paper
• Evidenz und Evidenzlücken für medikamentös zu behandelnde, nicht-tumoröse Erkrankungen im Gebiet der HNO-Heilkunde

  2016cites this paper
• Angioedema Phenotypes: Disease Expression and Classification

  2016cites this paper
• Bradykinin-mediated angioedema.

  2016cites this paper
• Isolated Visceral Angioedema Induced by Angiotensin-Converting Enzyme Inhibitor

  2015cites this paper
• Effect of C1‐Esterase‐inhibitor in angiotensin‐converting enzyme inhibitor‐induced angioedema

  2015cites this paper
• [WAO Guideline for the Management of Hereditary Angioedema].

  2015cites this paper
• ADVERSE DRUG REACTIONS IN THE ORAL CAVITY.

  2015cites this paper
• Evaluating for seasonal variation in angiotensin-converting enzyme inhibitor- and angiotensin receptor blocker-induced angioedema.

  2014cites this paper
• Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group

  2014cites this paper
• Angiotensin-converting enzyme inhibitor-induced angioedema--a dangerous new epidemic.

  2014cites this paper
• Neprilysin inhibition in chronic kidney disease

  2014cites this paper
• Hereditary angioedema: what the gastroenterologist needs to know

  2014cites this paper
• Evaluating for seasonal variation in angiotensin-converting enzyme inhibitoreand angiotensin receptor blocker-induced angioedema

  2014cites this paper
• Angioedèmes bradykiniques en Haute‐Normandie : étude rétrospective de 56 cas

  2014cites this paper
• The influence of trigger factors on hereditary angioedema due to C1-inhibitor deficiency

  2014cites this paper
• Iatrogenic angioedema associated with ACEi, sitagliptin, and deficiency of 3 enzymes catabolizing bradykinin.

  2014cites this paper
• Prise en charge des angiœdèmes induits par les inhibiteurs de l’enzyme de conversion de l’angiotensine : recommandations du Centre de référence national des angiœdèmes

  2013cites this paper
• Current pharmacotherapy of bradykinin-mediated angioedema

  2013cites this paper
• Bradykinin-mediated angioedema: factors prompting ED visits.

  2013cites this paper
• Overview of hereditary angioedema caused by C1-inhibitor deficiency: assessment and clinical management.

  2013cites this paper
• Angioedema induced by angiotensin-converting enzyme inhibitors

  2013cites this paper
• [Management of angiotensin-converting enzyme inhibitor-related angioedema: recommendations from the French National Center for Angioedema].

  2013cites this paper
• Life-Threatening ACE Inhibitor-Induced Angioedema After Eleven Years on Lisinopril

  2013cites this paper
• New trends in the prevention and management of community-acquired pneumonia.

  2012cites this paper
• Are Patients Aware of Angiotensin-Converting Enzyme Inhibitor–Associated Adverse Effects?

  2012cites this paper
• Meta-analysis of randomized trials of angioedema as an adverse event of renin-angiotensin system inhibitors.

  2012cites this paper
• Recent Advances in Drug-Induced

  2012cites this paper
• Recent advances in drug-induced angioedema.

  2012cites this paper
• Series : Advances in Consensus , Pathogenesis and Treatment of Urticaria and Angioedema Recent Advances in Drug-Induced Angioedema

  2012cites this paper
• L’angiœdème laryngé induit par les médicaments interférant avec le métabolisme de la bradykinine

  2012cites this paper
• ANNEE UNIVERSITAIRE 2012-2013 U.F.R. DE MEDECINE-PHARMACIE DE ROUEN

  2012cites this paper
• Bradykinin-receptor antagonist icatibant: possible treatment for ACE inhibitor-related angio-oedema.

  2012cites this paper
• Current and Emerging Management Options for Hereditary Angioedema in the US

  2012cites this paper
• WAO Guideline for the Management of Hereditary Angioedema

  2012cites this paper
• Possible Angiotensin-Converting Enzyme Inhibitor (ACEI)-Induced Small Bowel Angioedema

  2011cites this paper
• [Delayed angioedema during therapy with angiotensin-converting enzyme inhibitors].

  2011cites this paper
• Urticaria and angioedema.

  2011cites this paper
• [Bradykinin-mediated angioedema secondary to angiotensin converting enzyme: initiate treatment from the prehospital phase].

  2011cites this paper
• Pathophysiology of Hereditary Angioedema

  2011cites this paper
• Conestat alfa for the treatment of angioedema attacks

  2011cites this paper
• Immune response in human pathology: hypersensitivity and autoimmunity

  2011cites this paper
• Enapranil-Induced Angioedema in a 2-Year-Old Infant: Case Report

  2011cites this paper
• Angiœdème bradykinique secondaire aux inhibiteurs de l’enzyme de conversion : instaurer le traitement en préhospitalier

  2011cites this paper
• Kallikrein-kinin-system in angioedema

  2011cites this paper
• Oropharyngeal angioneurotic edema due to recombinant tissue plasminogen activator following massive pulmonary thromboembolism.

  2011cites this paper
• Visceral angioedema due to angiotensin-converting enzyme inhibitor therapy

  2011cites this paper
• Genetic and biochemical analysis of ACE inhibitor-induced angioedema in black and coloured South Africans

  2011cites this paper
• Angioedema hereditário Hereditary angioedema

  2010cites this paper
• Investigating Possible Anaphylactio Deaths

  2010cites this paper
• Potential genetic risk factors in angiotensin-converting enzyme-inhibitor-induced angio-oedema.

  2010cites this paper
• Angiotensin converting enzyme inhibitor induced angio‐oedema: a review of the pathophysiology and risk factors

  2009cites this paper
• Supraglottic swelling may not correlate with tongue swelling in angiotensin converting enzyme inhibitor‐induced angioedema

  2009cites this paper
• Angiotensin converting enzyme (ACE) inhibitory peptides: production and implementation of functional food.

  2009cites this paper
• Airway management and acute upper-airway obstruction

  2009cites this paper
• Angiotensin-converting enzyme inhibitor-induced angioedema in a community hospital emergency department.

  2009cites this paper
• Therapeutic potential of icatibant (HOE-140, JE-049)

  2008cites this paper